
Genviral is a biotechnology company focused on developing innovative viral vector technologies for gene therapy and vaccine applications. The company specializes in creating advanced solutions for the delivery of genetic material, aiming to enhance therapeutic efficacy and safety. Genviral's expertise lies in leveraging viral mechanisms to facilitate targeted gene delivery, which has potential applications in treating various genetic disorders and infectious diseases. The company is committed to advancing the field of gene therapy through its cutting-edge research and development initiatives.